Francesca Mo

527 total citations · 1 hit paper
15 papers, 342 citations indexed

About

Francesca Mo is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, Francesca Mo has authored 15 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Genetics and 6 papers in Oncology. Recurrent topics in Francesca Mo's work include Brain Metastases and Treatment (9 papers), Glioma Diagnosis and Treatment (8 papers) and Lung Cancer Research Studies (3 papers). Francesca Mo is often cited by papers focused on Brain Metastases and Treatment (9 papers), Glioma Diagnosis and Treatment (8 papers) and Lung Cancer Research Studies (3 papers). Francesca Mo collaborates with scholars based in Italy, Austria and Switzerland. Francesca Mo's co-authors include Roberta Rudà, Alessia Pellerino, Riccardo Soffietti, Federica Franchino, Francesco Bruno, Yu Guang, Patrick Devos, Martin J. van den Bent, Katharina Seystahl and Michael Weller and has published in prestigious journals such as International Journal of Molecular Sciences, Annals of Oncology and European Spine Journal.

In The Last Decade

Francesca Mo

13 papers receiving 336 citations

Hit Papers

Blood–Brain Barrier in Brain Tumors: Biology and Clinical... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Mo Italy 7 174 148 124 60 40 15 342
Barbara O’Brien United States 14 170 1.0× 239 1.6× 180 1.5× 108 1.8× 27 0.7× 56 478
Marta Padovan Italy 13 79 0.5× 282 1.9× 90 0.7× 91 1.5× 38 0.9× 47 435
Alicia Lenzen United States 7 75 0.4× 84 0.6× 133 1.1× 183 3.0× 26 0.7× 25 437
Rina Rubinstein Israel 7 73 0.4× 68 0.5× 187 1.5× 44 0.7× 39 1.0× 8 505
Katherine Ryan United States 4 69 0.4× 220 1.5× 80 0.6× 115 1.9× 36 0.9× 5 400
Michael Schulz Germany 6 166 1.0× 80 0.5× 172 1.4× 96 1.6× 34 0.8× 10 348
Andrey S. Bryukhovetskiy Russia 13 55 0.3× 107 0.7× 113 0.9× 113 1.9× 21 0.5× 30 350
Federica Franchino Italy 10 157 0.9× 153 1.0× 113 0.9× 48 0.8× 16 0.4× 19 333
Yoshie Umemura United States 10 80 0.5× 209 1.4× 66 0.5× 108 1.8× 32 0.8× 43 387
Katja Niesel Germany 5 157 0.9× 72 0.5× 167 1.3× 93 1.6× 31 0.8× 6 333

Countries citing papers authored by Francesca Mo

Since Specialization
Citations

This map shows the geographic impact of Francesca Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Mo more than expected).

Fields of papers citing papers by Francesca Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Mo. The network helps show where Francesca Mo may publish in the future.

Co-authorship network of co-authors of Francesca Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Mo. A scholar is included among the top collaborators of Francesca Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Mo. Francesca Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Pascuzzo, Riccardo, Roberta Rudà, Peter B. Barker, et al.. (2025). Glutamate to GABA ratio is elevated in patients with IDH-mutant lower-grade gliomas and seizures. Neuro-Oncology Advances. 7(1). vdaf155–vdaf155.
3.
Pellerino, Alessia, Francesco Bruno, Francesca Mo, et al.. (2022). P11.26.A STAT3 expression in brain metastases from breast cancer: correlations with different molecular subtypes and clinical outcome. Neuro-Oncology. 24(Supplement_2). ii62–ii62. 1 indexed citations
4.
Mo, Francesca, Daniela Gottardi, Rosa Palmiero, et al.. (2021). Richter’s Syndrome of the Central Nervous System. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48(6). 1–4. 1 indexed citations
5.
Pellerino, Alessia, Rosa Palmiero, Francesco Bruno, et al.. (2021). P14.42 Neratinib for treatment of leptomeningeal metastases from HER2-positive breast cancer in extended access program: preliminary results. Neuro-Oncology. 23(Supplement_2). ii46–ii46. 3 indexed citations
6.
Mo, Francesca, Alessia Pellerino, Riccardo Soffietti, & Roberta Rudà. (2021). Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance. International Journal of Molecular Sciences. 22(23). 12654–12654. 157 indexed citations breakdown →
7.
Mo, Francesca, Alessia Pellerino, & Roberta Rudà. (2021). Subependymal Giant Cell Astrocytomas (SEGAs): a Model of Targeting Tumor Growth and Epilepsy. Current Treatment Options in Neurology. 23(6). 1 indexed citations
8.
Rhun, Émilie Le, Patrick Devos, Johannes Weller, et al.. (2020). Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors. Neuro-Oncology. 23(7). 1100–1112. 69 indexed citations
9.
Pellerino, Alessia, et al.. (2020). Management of Brain and Leptomeningeal Metastases from Breast Cancer. International Journal of Molecular Sciences. 21(22). 8534–8534. 21 indexed citations
10.
Rudà, Roberta, Francesca Mo, & Alessia Pellerino. (2020). Epilepsy in brain metastasis: an emerging entity. Current Treatment Options in Neurology. 22(2). 6–6. 23 indexed citations
11.
Pellerino, Alessia, Francesca Mo, Francesco Bruno, et al.. (2020). Leptomeningeal metastases from non-small cell lung cancer: state of the art and recent advances. Journal of Cancer Metastasis and Treatment. 2020. 11 indexed citations
12.
Rhun, Émilie Le, Patrick Devos, Johannes Weller, et al.. (2020). NCOG-02. PROGNOSTIC VALIDATION OF THE EANO ESMO CLASSIFICATION OF LEPTOMENINGEAL METASTASIS. Neuro-Oncology. 22(Supplement_2). ii129–ii129. 1 indexed citations
13.
Guang, Yu, et al.. (2019). The value of detecting pepsinogen and gastrin-17 levels in serum for pre-cancerous lesion screening in gastric cancer. Neoplasma. 66(4). 637–640. 23 indexed citations
14.
Rhun, Émilie Le, Patrick Devos, Johannes Weller, et al.. (2019). Prognostic role of the EANO ESMO classification of leptomeningeal metastases. Annals of Oncology. 30. v144–v144. 3 indexed citations
15.
Rudà, Roberta, Alessia Pellerino, Federica Franchino, et al.. (2017). Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study. Journal of Neuro-Oncology. 136(1). 105–114. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026